Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Microfluidics Market: By Material: Polymer, Glass, Silicon, Others; By Application: Pharmaceuticals, Genomics, Proteomics, Cell Based Assays, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments
Global Microfluidics Market Outlook
The global microfluidics market reached a value of around USD 12 billion in 2020. The microfluidics market is further anticipated to grow at a CAGR of 23.12% over the forecast period of 2022-2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing prevalence of chronic and infectious illnesses, combined with advancements in coagulation testing, blood gas electrolytes, haematology, urine chemistry, and cardiovascular markers, are creating fresh possibilities for the development of the microfluidics market. The demand for microfluidics technology integration in POC diagnostic systems, manufacturing, fluid handling systems, and signal detection processes is increasing. In the coming years, this is anticipated to boost the microfluidics market further.
Global Microfluidics Market: Properties and Applications
Microfluidics deals with the behaviour, accurate control, and manipulation of liquids that are geometrically restricted to a small scale, typically submillimeter, at which capillary penetration regulates mass transport.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global microfluidics market can be divided based on segments like material and application.
The industry can be divided based on its material as polymer, glass, and silicon, among others.
The microfluidics market can be broadly categorised on the basis of its application into:
- Pharmaceuticals
- Genomics
- Proteomics
- Cell Based Assays
- Others
The EMR report looks into the regional microfluidics markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Microfluidics Market Analysis
The rising demand for point-of-care (POC) testing due to the rising incidence of chronic infectious diseases, the growing demand for equipment integrated with microfluidic technology, faster testing and improved portability through microfluidic chip miniaturisation, and the development of innovative microfluidics technology, along with launch of new products, are some of the major factors driving the growth of the global microfluidics market. Challenges while incorporating the microfluidics technology into existing workflows coupled with the presence of complex and time-consuming regulatory standards are the factors which may restrain the growth of the microfluidics market up to some extent in the future.
Global Microfluidics Market: Competitive Landscape
The report presents a detailed analysis of the following key players in the global microfluidics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc. (NASDAQ: ILMN)
- Agilent Technologies Inc
- Caliper Life Sciences
- Cepheid Inc
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Others
The EMR report gives an in-depth insight into the microfluidics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Material, Application, Region |
| Breakup by Material | Polymer, Glass, Silicon, Others |
| Breakup by Application | Pharmaceuticals, Genomics, Proteomics, Cell Based Assays and Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Illumina, Inc. (NASDAQ: ILMN), Agilent Technologies Inc (NYSE: A), Caliper Life Sciences, Cepheid Inc, Danaher Corporation (NYSE: DHR), Bio-Rad Laboratories, Inc. (NYSE: BIO), Abbott Laboratories (NYSE: ABT), Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Microfluidics Market Analysis
8.1 Key Industry Highlights
8.2 Global Microfluidics Historical Market (2017-2021)
8.3 Global Microfluidics Market Forecast (2022-2027)
8.4 Global Microfluidics Market by Material
8.4.1 Polymer
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Glass
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Silicon
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Others
8.5 Global Microfluidics Market by Application
8.5.1 Pharmaceuticals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Genomics
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Proteomics
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Cell Based Assays
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Others
8.6 Global Microfluidics Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Illumina, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Agilent Technologies, Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Cepheid
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Bio-Rad Laboratories, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Caliper Life Sciences Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Danaher Corporation
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Abbott Laboratories
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Microfluidics Market: Key Industry Highlights, 2017 and 2027
2. Global Microfluidics Historical Market: Breakup by Material (USD Billion), 2017-2021
3. Global Microfluidics Market Forecast: Breakup by Material (USD Billion), 2022-2027
4. Global Microfluidics Historical Market: Breakup by Application (USD Billion), 2017-2021
5. Global Microfluidics Market Forecast: Breakup by Application (USD Billion), 2022-2027
6. Global Microfluidics Historical Market: Breakup by Region (USD Billion), 2017-2021
7. Global Microfluidics Market Forecast: Breakup by Region (USD Billion), 2022-2027
8. North America Microfluidics Historical Market: Breakup by Country (USD Billion), 2017-2021
9. North America Microfluidics Market Forecast: Breakup by Country (USD Billion), 2022-2027
10. Europe Microfluidics Historical Market: Breakup by Country (USD Billion), 2017-2021
11. Europe Microfluidics Market Forecast: Breakup by Country (USD Billion), 2022-2027
12. Asia Pacific Microfluidics Historical Market: Breakup by Country (USD Billion), 2017-2021
13. Asia Pacific Microfluidics Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Latin America Microfluidics Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Latin America Microfluidics Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Middle East and Africa Microfluidics Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Middle East and Africa Microfluidics Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Global Microfluidics Market Structure
Key Questions Answered in the Report
In 2020, the global microfluidics market attained a value of nearly USD 12 billion.
The market is projected to grow at a CAGR of 23.12% between 2021 and 2026.
The major drivers of the industry, such as the increasing population, growing incidences of chronic and infectious diseases, developing healthcare sector, advancements in biotechnology, and growing clinical trials, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing R&D activities and increasing demand for point-of-care (POC) testing, coupled with the integration of microfluidics technology in POC diagnostic systems.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major microfluidics materials available in the industry are polymer, glass, and silicon, among others.
The significant applications of microfluidics include pharmaceuticals, genomics, proteomics, and cell based assays and others.
The major players in the industry are Illumina, Inc., Agilent Technologies Inc, Caliper Life Sciences, Cepheid Inc, Danaher Corporation, Bio-Rad Laboratories, Inc., and Abbott Laboratories, among others.
Analyst Review
The global microfluidics market attained a value of USD 12 billion in 2020, driven by the growing cases of chronic and other diseases and advancements in biotechnology. Aided by the growing research and development activities, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 23.12%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on materials, the microfluidics industry can be segmented into polymer, glass, silicon, and others. On the basis of applications, the industry is divided into pharmaceuticals, genomics, proteomics, and cell based assays and others. The major regional markets for microfluidics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Agilent Technologies Inc, Caliper Life Sciences, Cepheid Inc, Danaher Corporation, Bio-Rad Laboratories, Inc., and Abbott Laboratories, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global cardiac troponin market has been driven by the increasing prevalence of acute coronary syndrome in the historical period. Aided by the increasing investments and rising demand for cardiac b...
The global gas chromatography market attained a value of nearly USD 2.92 billion in 2021, driven by the growing product demand in major end use industries, and rapid urbanisation. Aided by the growing...
The global B-hydroxybutyrate (ketone body) assay kits market is driven by the rising end uses of the product in hospitals and clinics. Aided by the growing R&D activities, the market is expected to wi...
The global clinical diagnostics market attained a value of more than USD 63.41 billion in 2021, driven by the rising prevalence of chronic diseases, increasing geriatric population, and rising healthc...
The global non-invasive prenatal testing (NIPT) market attained a value of about USD 1.74 billion in 2021, driven by the rising incidence of chromosomal abnormalities. Aided by the growing technologic...
NEWSLETTER